alnylam
The Director of Cyber Architecture & Engineering defines and drives the cybersecurity architecture strategy to enable innovation while protecting the company's science, patients, and people. This leader translates strategy into actionable standards and roadmaps, ensuring security is embedded into enterprise initiatives from inception through delivery. The role involves leading the design of a Zero Trust architecture, establishing governance for architecture reviews, and mentoring a team of security architects and engineers.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2002
Alnylam is a biopharmaceutical company that has pioneered RNA interference (RNAi) therapeutics, an innovative class of medicines that treats diseases by silencing the genes that cause or contribute to them. The company develops RNAi-based medicines targeting both rare and prevalent diseases across multiple therapeutic areas, with approved products and a robust investigational pipeline. Driven by science and inspired by patients, Alnylam is committed to delivering transformational medicines that address diseases at their genetic source.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for alnylam.
Director of Enterprise Cyber Security Architecture
Hewlett Packard Enterprise
Director of Enterprise Cyber Security Architecture
Hewlett Packard Enterprise
Director of Enterprise Cyber Security Architecture
Hewlett Packard Enterprise
Director, Identity & Access Management Architecture
Alcon
Zero Trust Cyber Security Engineer
Leidos
Lead Security Architect
C0001088737P